The Ludwig Scale: Classifying Female Pattern Hair Loss
The Ludwig Scale is the most widely used clinical framework for grading female pattern hair loss (FPHL), providing physicians with a standardized language for documenting and communicating the severity of diffuse crown thinning in women. Developed by German dermatologist Erich Ludwig and published in the British Journal of Dermatology in 1977, the scale organizes visible hair loss into three graduated grades. Understanding how the scale works is foundational to treatment planning, candidacy assessment, and outcome measurement in hair restoration for women.
Definition and scope
Female pattern hair loss is the most common cause of hair loss in women, affecting an estimated 40% of women by age 50 according to the American Academy of Dermatology (AAD). Unlike male androgenetic alopecia — which typically follows a receding frontal hairline — FPHL presents primarily as diffuse thinning over the crown and top of the scalp while the frontal hairline is largely preserved.
The Ludwig Scale (Ludwig E., Br J Dermatol, 1977) provides the classification structure most dermatologists and hair restoration surgeons reference when documenting this pattern. Its scope is limited to androgenetic FPHL and does not classify scarring alopecias, alopecia areata, or traction-related hair loss — conditions that require separate diagnostic frameworks.
The scale operates alongside other clinical tools. The Sinclair Scale, a 5-point photographic reference published in 2004, offers an alternative grading system with finer gradations and photographic anchors, making it useful in research settings. The Ludwig Scale, however, remains the dominant clinical reference in the United States, and understanding it is essential reading for anyone navigating hair restoration for women.
How it works
The Ludwig Scale assigns one of three grades based on the visible density and distribution of hair thinning over the crown zone, defined as the area bounded anteriorly by a line 1 centimeter behind the frontal hairline.
Grade I (Mild)
Perceptible thinning in the crown zone, with adequate residual density that the scalp is not plainly visible to the casual observer. The frontal hairline is fully intact. Parting width is slightly widened compared to baseline.
Grade II (Moderate)
More pronounced rarefaction over the crown. The central part line is noticeably widened and thinning is visible even when hair is styled to conceal it. The frontal hairline remains intact, but overall volume over the vertex is substantially reduced.
Grade III (Advanced)
Full or near-full denudation of the crown zone. The scalp is clearly visible across a broad area. A thin band of preserved hair at the frontal margin typically remains, but hair density in the central and posterior crown regions is severely depleted.
The grading process involves direct clinical inspection under adequate lighting, often supplemented by dermoscopy to assess follicular miniaturization at the scalp level. The AAD guidelines for evaluating hair disorders recommend baseline photography using standardized positioning — typically vertex, anterior hairline, and bilateral parting views — to enable reproducible Grade comparisons across clinic visits (AAD Clinical Practice Guidelines).
Common scenarios
Three clinical presentations account for the majority of Ludwig Scale assessments in practice:
-
Grade I presentation in women aged 25–40: Thinning is first noticed at the central part line. Patients frequently report a widening part or increased scalp visibility under bright light. Dermoscopy at this stage often reveals a mixture of miniaturized and terminal follicles, suggesting active androgenetic activity. Medical therapies — primarily topical minoxidil, which is FDA-approved for women at a 2% concentration (FDA drug labeling, Minoxidil Topical Solution) — are the primary intervention at Grade I.
-
Grade II presentation with diffuse volume loss: The crown zone shows visible thinning across a broad field. Styling camouflage is increasingly insufficient. At this grade, candidates may be evaluated for low-level laser therapy, platelet-rich plasma protocols, or, in selected cases, surgical hair restoration. Decisions about transplant candidacy at Grade II require careful assessment of donor density and the likelihood of future progression.
-
Grade III presentation with advanced crown loss: Dense coverage of the crown region is absent. Surgical planning becomes significantly more complex because the recipient zone is large and donor supply — drawn from the occipital and parietal zones — is finite. Patients with Grade III loss are also evaluated for concurrent miniaturization in the donor area, which can affect long-term graft survival.
The Norwood Scale, used for classifying male hair loss, is not interchangeable with the Ludwig Scale. Male pattern loss begins at the frontal hairline and temples; female pattern loss begins at the crown. Applying the Norwood framework to female patients produces clinically inaccurate stage assignments.
Decision boundaries
The Ludwig Scale structures clinical decision-making across four specific thresholds:
- Grade I → medical management: Miniaturization without significant density loss supports non-surgical intervention. Surgical candidacy is generally deferred unless thinning is focal and donor density is excellent.
- Grade I → Grade II transition: Progression despite medical therapy signals a need to reassess hormonal contributors and consider additional diagnostics, including serum ferritin, thyroid panel, and androgen levels per AAD guidance.
- Grade II → surgical evaluation: Stable Grade II loss with adequate donor density may qualify for hair transplant. Stability — typically defined as no measurable progression over 12 months — is a core criterion, as detailed in regulatory and procedural context for hair restoration.
- Grade III → complex planning: Advanced loss triggers a donor-to-recipient ratio calculation. If coverage of the entire Grade III zone would require more grafts than the donor area can safely yield, staged procedures or combined medical-surgical protocols are considered.
The Ludwig Scale does not encode information about the rate of loss, hormonal etiology, or response to prior treatment. Its value is in providing a reproducible, universally understood severity description — a common reference point across dermatology, surgery, and research that anchors the broader hair restoration reference framework used by clinicians and patients alike.
References
- Ludwig E. "Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex." British Journal of Dermatology, 1977
- American Academy of Dermatology — Hair Disorders Clinical Practice Guidelines
- FDA Drug Labeling Database — Minoxidil Topical Solution
- Sinclair R, et al. "A new scale for the assessment of female androgenetic alopecia." Journal of the American Academy of Dermatology, 2004
- National Institutes of Health MedlinePlus — Hair Loss
The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)